Warrant Number. WC-1 Void after ------------ WARRANT TO PURCHASE COMMON STOCK OF FAROUDJA RESEARCH ENTERPRISES, INC. This certifies that, for value received, Xxxx Sie is entitled, subject to the terms set forth below, to purchase from Faroudja Research Enterprises, Inc. (the "Company"), a California corporation, up to 58,950 shares (the "Shares") of fully paid and non-assessable shares of Common Stock of the Company at the price of $.50 per share (the "Exercise Price") at the times and subject to the conditions hereafter stated, such price and number of Shares being subject to adjustment as herein provided in this Warrant.
Warrant Number number assigned by the court when the warrant is issued. This is a required field if neither the NCIC Number nor the OCA Number is available. (C) Subject’s Race—use the following NCIC standard codes for race. Race Code American Indian or Alaskan Native I Asian or Pacific Islander A Black B White W Unknown U If NCIC standard race codes are not used, leave this field blank. (Opt)
Warrant Number. No. of Shares For Which this Warrant is Initially Exercisable:
Warrant Number. No. of Shares For Which this Warrant is Initially Exercisable: Issue Date: Termination Date: WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK OF HELIX BIOMEDIX, INC. THIS CERTIFIES THAT, for valuable consideration, the undersigned, together with his successors and permitted assigns (the “Holder”) is entitled to purchase, subject to the terms set forth below, up to shares of duly authorized, validly issued, fully paid and nonassessable shares of common stock, $0.001 par value per share (the “Common Stock”), of Helix BioMedix, Inc., a Delaware corporation (the “Company”).
Warrant Number. The first sentence of the first paragraph of the Existing Warrant beginning “THIS CERTIFIES THAT” is deleted and replaced in its entirety with the following: THIS CERTIFIES THAT, for value received, Hercules Technology III, L.P., a Delaware limited partnership (“Holder”), is entitled to subscribe for and purchase One Million Five Hundred Forty-Eight Thousand Three Hundred Eighty-Seven (1,548,387) fully paid and nonassessable shares of Common Stock of Amedica Corporation, a Delaware corporation (“Company”) subject to the provisions and upon the terms and conditions hereinafter set forth.
Warrant Number. W__ This certifies that, for value received, and subject to the terms and conditions set forth below, _________________, or its registered assigns, is entitled to purchase from R.A.B. HOLDINGS, INC., a Delaware corporation (the "Company"), __________ shares (or such other number of shares as may be determined in accordance with Section 6 hereof) of the common stock, par value $.01 per share, of the Company (the "Common Stock"), at an exercise price of $0.01 per share (the "Exercise Price"), upon surrender of this Warrant at the principal office of the Company referred to below, with the notice of exercise form attached hereto duly executed and the simultaneous payment of the Exercise Price or, in lieu of payment of such Exercise Price, by indication on the exercise form that the conversion method provided in Section 2(c) has been elected in connection with such exercise. This Warrant is one of the Warrants (the "Warrants") originally issued in connection with the execution and delivery of the Securityholders Agreement dated as of May 1, 2002 (the "Securityholders Agreement") by and among the Company and the Securityholders party thereto. Certain capitalized terms used in this Warrant are defined in Section 7.
Warrant Number. No. of Shares For Which this Warrant is Initially Exercisable: [] Issue Date: June 30, 2008 Termination Date: June 30, 2013 WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK OF HELIX BIOMEDIX, INC. THIS CERTIFIES THAT, for valuable consideration, the undersigned, together with his successors and permitted assigns (the “Holder”) is entitled to purchase, subject to the terms set forth below, up to shares of duly authorized, validly issued, fully paid and nonassessable shares of common stock, $0.001 par value per share (the “Common Stock”), of Helix BioMedix, Inc., a Delaware corporation (the “Company”). This Warrant shall be issued and be exercisable only in the event that the Company does not consummate an Equity Financing (as defined in the Convertible Promissory Note issued to the Holder on February 14, 2008) on or before June 29, 2008.
Warrant Number. The definition of "Warrant Number" contained in Section 1.0 of the Warrant shall be deleted in its entirety and replaced with the following:
Warrant Number. The Warrant Number shall be determined as follows: N = A/E Where:
